5 employees
Ligature Therapeutics is a biotech company that develops small molecules for targeted protein degradation to treat intractable diseases.
2020
$6M
from 1 investors over 1 rounds
Ligature Therapeutics raised $6M on January 4, 2021
Investors: Lightstone Ventures